MS4A2 rs1801177: Understanding the IgE Receptor Variant
The rs1801177 variant is a genetic change located within the MS4A2 gene, which encodes a critical component of the high-affinity IgE receptor. This receptor is essential for allergic responses, and the variant has been statistically associated with traits such as atopic dermatitis, bronchial asthma, and elevated serum IgE levels.
What each genotype means
Baseline IgE receptor profile
This genotype represents the common baseline state for the MS4A2 gene in many populations. Research into this variant suggests associations with atopic conditions, but the evidence remains limited and may depend on maternal inheritance patterns or specific ancestral backgrounds. This result does not provide a medical diagnosis or predict individual health outcomes.
This is the most common genotype in many global populations, though frequencies vary significantly by ancestry.
Variant IgE receptor profile
Carrying one copy of the G allele is associated with the MS4A2 gene, which encodes a subunit of the high-affinity IgE receptor. Some studies suggest this variant may influence susceptibility to atopic dermatitis or asthma, though findings are inconsistent and often limited by small sample sizes or specific population contexts. Please discuss any concerns regarding allergic symptoms or immune health with your clinician.
This heterozygous genotype is found in approximately 15-22% of individuals of European ancestry.
Increased variant IgE profile
This genotype involves two copies of the G allele at the MS4A2 locus. While this variant has been studied in the context of elevated total serum IgE and allergic conditions, the clinical significance is not well-established and evidence remains limited. This information should not be used to guide medical decisions; consult a healthcare provider for personalized health advice.
This homozygous genotype is less common than the A/A or A/G states in most studied populations.
What is rs1801177 and Where is it Located?
The variant rs1801177 is a single nucleotide polymorphism (SNP) situated within the MS4A2 gene. This gene is located on chromosome 11q13, a region long recognized in genetic research for its involvement in atopic conditions. A SNP represents a variation at a single position in the DNA sequence, where one nucleotide is replaced by another. In the case of rs1801177, researchers track the specific alleles present at this location to understand how they might influence the function of the protein encoded by the gene. Because this variant sits within a gene responsible for immune system signaling, scientists have focused on it as a potential contributor to the genetic architecture of allergic diseases.
The Role of the MS4A2 Gene
The MS4A2 gene provides instructions for creating the beta subunit of the high-affinity IgE receptor, also known as FcεRI. This receptor is primarily found on the surface of mast cells and basophils, which are key players in the body's immune response. When an allergen binds to IgE antibodies attached to these receptors, it triggers a cascade of signals that lead to the release of inflammatory mediators, such as histamine. These mediators are responsible for the classic symptoms of an allergic reaction. By encoding the beta subunit, MS4A2 helps stabilize the receptor and amplify the signaling process. Consequently, variations in this gene may influence how sensitive an individual's immune system is to environmental triggers.
Research Associations and Evidence Strength
Research into rs1801177 and other MS4A2 variants has primarily focused on their statistical association with allergic phenotypes, including bronchial asthma, atopic dermatitis, and elevated total serum IgE levels. While several studies have identified correlations between these variants and allergic traits, the evidence strength is generally considered limited. Genetic associations in complex conditions like asthma are often influenced by multiple genes, environmental factors, and gene-environment interactions, making it difficult to isolate the effect of a single SNP. Furthermore, findings have sometimes been inconsistent across different ethnic populations, suggesting that the impact of this variant may be ancestry-specific or dependent on other genetic modifiers. It is important to view these associations as statistical trends observed in large groups rather than definitive predictors for any single individual.
Population Frequency
The prevalence of the rs1801177 variant varies across different global populations. In European populations, the minor allele frequency is approximately 0.15 to 0.22. These frequencies are derived from large-scale genomic databases, which help researchers understand the distribution of genetic diversity. Because allele frequencies can differ significantly between ancestral groups, it is essential to consider population context when interpreting genetic data. The presence of a specific allele does not guarantee the development of any condition, as most common diseases are polygenic and influenced by a wide array of internal and external factors.
Interpreting Your Genetic Information
Understanding your genetic variants can be an educational journey, but it is vital to maintain a realistic perspective on what this information means for your health. A genetic association with a trait like asthma does not constitute a medical diagnosis. Many factors, including lifestyle, environment, and other genetic markers, contribute to the development of allergic conditions. You cannot use this information to diagnose yourself or to make changes to medical treatments. If you have concerns about asthma, allergies, or your immune health, the most appropriate step is to consult with a qualified healthcare provider or an allergist. They can provide a comprehensive evaluation based on your clinical history and symptoms, which are far more predictive of health outcomes than any single genetic variant.
How common is this variant?
The minor allele frequency for rs1801177 is approximately 0.15-0.22 in European populations, with variations observed across other global ancestries.
Frequently asked questions
Does having the rs1801177 variant mean I will develop asthma?
No, having this variant does not mean you will develop asthma. Asthma is a complex condition influenced by many genetic and environmental factors, and a single SNP is not a diagnostic tool.
Can I use this genetic information to change my allergy medication?
You should never change your medication based on genetic test results. Always discuss your treatment plan and any concerns about your medications with your doctor or pharmacist.
Is rs1801177 the only gene associated with allergies?
No, allergies and asthma are polygenic, meaning they are associated with many different genes. MS4A2 is just one of many genetic markers that researchers have studied in relation to these conditions.
Where can I find more information about my specific genetic results?
If you have received genetic testing results, the best resource is a genetic counselor or your primary healthcare provider. They can help you interpret the findings in the context of your personal and family health history.
Sources & further reading
Educational information only, last refreshed 9/21/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1801177?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29